| Aug 2 |
Should You Buy, Sell or Hold Gilead Sciences (GILD) Before Q2 Earnings?
|
| Aug 1 |
Gilead Sciences (GILD) Advances While Market Declines: Some Information for Investors
|
| Aug 1 |
Gilead Sciences (GILD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
| Jul 31 |
The Top 3 Biotech Stocks to Buy Now Summer 2024
|
| Jul 30 |
Compugen receives FDA approval for Phase I trial of solid tumour treatment
|
| Jul 29 |
Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know
|
| Jul 29 |
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
|
| Jul 29 |
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
|
| Jul 28 |
Gilead Sciences, Inc.'s (NASDAQ:GILD) one-year returns climbed after last week's 6.1% gain, institutional investors must be happy
|
| Jul 27 |
A Look At Gilead Sciences After Its Recent Weakness
|
